Search

everythinglearnresearchcommunity

for

Search:↓

Thymic transplantation normalized some T-cells but not others, maintaining immune function.

Patient-derived melanocytes can potentially treat vitiligo by restoring skin pigmentation.

The document concludes that anti-dsDNA antibodies are not unique to SLE and their use as indicators is doubtful, highlighting the need for better understanding and classification of the disease.

Anthralin is effective for psoriasis and alopecia with minimal systemic side effects but can irritate the skin.

The article concludes that developing in vitro models for human hair structures is important for research and reducing animal testing, but there are challenges like obtaining suitable samples and the models' limitations.

New treatments targeting immune pathways show promise for severe hair loss but need more research for safety and effectiveness.

Gonadal hormones significantly affect the severity of alopecia areata in mice.

Immune cells help regulate hair growth, and better understanding this can improve hair loss treatments.

Teriflunomide is effective and generally safe for treating relapsing-remitting multiple sclerosis.

Topical anthralin helped regrow hair in mice with a condition similar to human alopecia.

Some medications might reverse gray hair, especially those that reduce inflammation or stimulate pigment production, and vitamin B might help.

People with Lichen Planus, especially with mucosal involvement, are more likely to have Metabolic Syndrome, which increases their risk for heart disease and diabetes.

GMG-43AC may help reduce unwanted hair growth and treat certain hair loss conditions.

Immune cells affect hair growth and could lead to new hair loss treatments.

iNKT cells can help prevent and treat alopecia areata by promoting hair regrowth.

Safflower has been used in traditional medicine for centuries and shows promise in treating heart, brain, and inflammatory conditions, but more research is needed to ensure its safety.

IGF-1 affects hair loss and could be a potential treatment.

Diphencyprone treatment increases CD8 lymphocytes in the scalp, which is associated with hair regrowth in alopecia areata patients.

Some patients may experience temporary total hair loss from hepatitis C treatment with PEG-interferon and ribavirin.

Regenerative therapies show promise for treating vitiligo and alopecia areata.

AIRE-deficient rats developed severe autoimmune disease similar to APECED, useful for testing treatments.

Intralesional therapy for keratoacanthoma is effective and has fewer side effects than systemic treatments.

Imiquimod cream activates hair follicle stem cells and causes early hair growth by changing immune cells and certain protein expressions.

Genetic variants linked to ten skin diseases were found, showing both immune and non-immune factors play a role.

A man's skin condition, pemphigus vulgaris, came back after he was treated with interleukin 2 for cancer.

Some treatments like methotrexate with prednisone might help juvenile morphea, but more research is needed to confirm.

Thyroid diseases may contribute to autoimmune skin diseases, and more research is needed on their relationship.

Frontal Fibrosing Alopecia's cause is unclear, affects mainly postmenopausal women, and current treatments focus on stopping hair loss rather than regrowth.

Alopecia areata, a type of hair loss, is likely an autoimmune disease with a genetic link, but its exact cause is still unknown.

The current understanding of frontal fibrosing alopecia involves immune, genetic, hormonal factors, and possibly environmental triggers, but more research is needed for effective treatments.